Cellular Immunotherapy for Septic Shock

Clinical trial NCT03369275 · UNKNOWN

Trial details

NCT number: NCT03369275
Sponsor: Ottawa Hospital Research Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Septic Shock Sepsis Pathologic Processes Shock Infection Systemic Inflammatory Response Syndrome Inflammation

Start date: 2018-03-01
Primary completion: 2020-02-01
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.